Columbia University Irving Medical Center

Columbia research led to the first systemic treatment specifically developed for severe alopecia areata, an autoimmune disease that causes hair loss.

Most parechovirus infections are mild, but newborns and infants younger than 3 months are at increased risk of seizures, encephalitis, and meningitis.